p {color: #ffffff;}

Medtronic and ARMI | BioFabUSA to Speak at University of Minnesota for "Manufacturing Needs for Biofabrication of Engineered Tissues and Organs" Event on April 9th

 Becky Robinson-Zeigler, Deputy Chief Regulatory Officer at ARMI

Becky Robinson-Zeigler, Deputy Chief Regulatory Officer at ARMI

University of Minnesota will be hosting its annual “Design of Medical Devices Conference” April 10th-12th, 2018, which will be kicked off by a “Manufacturing Needs for Biofabrication of Engineered Tissues and Organs” portion on Monday the 9th. ARMI | BioFabUSA is pleased to be a part of this year’s event in which Becky Robinson-Zeigler, Deputy Chief Regulatory Officer at ARMI, will be addressing the audience on biofabrication technologies.

Attendees of this conference will learn from industry and academic experts on what is needed in order to bring biofabrication from its current stage to reproducible, manufactured tissue products. Experts like Robinson-Zeigler, who will be speaking on behalf of ARMI during a workshop titled, “Moving from Bioprinting to Biomanufacturing.”

The event will also feature short lectures, discussions, and brainstorming sessions, which include topics covering standards, scalable 3D biomanufacturing tools and processes, non-invasive monitoring of 3D bioprinted tissue, and others.

 Markus Reiterer, Senior Principle Scientist at Medtronic

Markus Reiterer, Senior Principle Scientist at Medtronic

For instance, breakthroughs in cell technologies, materials science and biofabrication methods, particularly with regards to 3D bioprinting, have laid a foundation for large-scale manufacturing of tissue and tissue-related technologies. Markus Reiterer, Senior Principle Materials Scientist at Medtronic and Co-Chair of the event, shared his thoughts regarding the up and coming field of biofabrication:

“It’s pretty obvious that with the advances in stem cell technology, computer science, engineering and 3D printing, we will one day be able to create bioartificial tissues and implantable organs. It’s been proven on a small scale that these things can be done. Then the question becomes how to get that work out of the lab and mass produced to help the most people.”

 Angela Panoskaltsis-Mortari, PhD, University of Minnesota

Angela Panoskaltsis-Mortari, PhD, University of Minnesota

The event is being hosted by Professor Angela Panoskaltsis-Mortari.  Dr. Panoskaltsis-Mortari is a Professor of Pediatrics in the Division of Blood and Marrow Transplantation and the Division of Pulmonary Medicine at the University of Minnesota. She also is a Professor of Medicine in the Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, the Director of the UMN 3D Bioprinting Facility and Vice Chair for Research for the Department of Pediatrics.  Her laboratory research focuses upon bioengineering the lung using adult stem cells and decellularized whole lung scaffolds with the goal of creating autologous lungs for transplant. 

Click here to learn more about this event or to register – we hope to see you there!